5 Experimental SMA Therapies You Might Find Interesting

3. Nusinersen

news_18_Artboard 343 copy 349

Biogen and Ionis Pharmaceuticals recently announced that nusinersen, their investigational drug for treating SMA, met the primary end point for the interim analysis of the ENDEAR Phase 3 trial evaluating nusinersen in infantile-onset SMA.

Find out more on how Nusinersen can be used to treat SMA.

Leave a Comment

Your email address will not be published. Required fields are marked *

Pin It on Pinterest

Share This